Andrew Schorr is a respected medical journalist and online broadcaster who is a patient himself, a 14-year chronic lymphocytic leukemia survivor. Andrew participated in a phase II clinical trial for a 3-drug combination (chemotherapy+Rituxan) and it has led to a 10 year deep remission. He is a strong advocate for participation in clinical trials and founder and host of programs on www.patientpower.info on the latest treatments and research. Patient Power's sponsors include M.D. Anderson Cancer Center, Penn Medicine, University of Washington, UCSF Medical Center, Genentech, Amgen, and BioMarin.